A single-center, randomized, non-inferiority study evaluating seroma formation after mastectomy combined with flap fixation with or without suction drainage: protocol for the Seroma reduction and drAin fRee mAstectomy (SARA) trial.
Drain free
Flap fixation
Mastectomy
Seroma
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
07 Aug 2020
07 Aug 2020
Historique:
received:
30
04
2020
accepted:
30
07
2020
entrez:
10
8
2020
pubmed:
10
8
2020
medline:
16
1
2021
Statut:
epublish
Résumé
Seroma formation is a common complication after breast cancer surgery and can lead to delayed wound healing, infection, patient discomfort and repeated visits to the outpatient clinic. Mastectomy combined with flap fixation is becoming standard practice and is currently combined with closed-suction drainage. There is evidence showing that closed-suction drainage may be insufficient in preventing seroma formation. There is reasonable doubt whether there is still place for closed-suction drainage after mastectomy when flap fixation is performed. We hypothesize that mastectomy combined with flap fixation and closed suction drainage does not cause a significant lower incidence of seroma aspirations, when compared to mastectomy and flap fixation alone. Furthermore, we expect that patients without drainage will experience significantly less discomfort and comparable rates of surgical site infections. This is a randomized controlled trial in female breast cancer patients undergoing mastectomy and flap fixation using sutures with or without sentinel lymph node biopsy (SLNB). Patients will be eligible for inclusion if they are older than 18 years, have an indication for mastectomy with or without sentinel procedure. Exclusion criteria are modified radical mastectomy, direct breast reconstruction, previous history of radiation therapy of the unilateral breast, breast conserving therapy and inability to give informed consent. A total of 250 patients will be randomly allocated to one of two groups: mastectomy combined with flap fixation and closed-suction drainage or mastectomy combined with flap fixation without drainage. Follow-up will be conducted up to six months postoperatively. The primary outcome is the proportion of patients undergoing one or more seroma aspirations. Secondary outcome measures consist of the number of invasive interventions, surgical site infection, quality of life measured using the SF-12 Health Survey, cosmesis, pain and number of additional outpatient department visits. To our knowledge, no randomized controlled trial has been conducted comparing flap fixation with and without closed-suction drainage with seroma aspiration as the primary outcome. This study could result in finding evidence that supports performing mastectomy without closed-suction drainage. This trial was approved by the medical ethical committee of Zuyderland Medical Center METC-Z on 20 March 2019 (METCZ20190023). The SARA Trial was registered at ClinicalTrials.gov as per July 2019, Identifier: NCT04035590 .
Sections du résumé
BACKGROUND
BACKGROUND
Seroma formation is a common complication after breast cancer surgery and can lead to delayed wound healing, infection, patient discomfort and repeated visits to the outpatient clinic. Mastectomy combined with flap fixation is becoming standard practice and is currently combined with closed-suction drainage. There is evidence showing that closed-suction drainage may be insufficient in preventing seroma formation. There is reasonable doubt whether there is still place for closed-suction drainage after mastectomy when flap fixation is performed. We hypothesize that mastectomy combined with flap fixation and closed suction drainage does not cause a significant lower incidence of seroma aspirations, when compared to mastectomy and flap fixation alone. Furthermore, we expect that patients without drainage will experience significantly less discomfort and comparable rates of surgical site infections.
METHODS
METHODS
This is a randomized controlled trial in female breast cancer patients undergoing mastectomy and flap fixation using sutures with or without sentinel lymph node biopsy (SLNB). Patients will be eligible for inclusion if they are older than 18 years, have an indication for mastectomy with or without sentinel procedure. Exclusion criteria are modified radical mastectomy, direct breast reconstruction, previous history of radiation therapy of the unilateral breast, breast conserving therapy and inability to give informed consent. A total of 250 patients will be randomly allocated to one of two groups: mastectomy combined with flap fixation and closed-suction drainage or mastectomy combined with flap fixation without drainage. Follow-up will be conducted up to six months postoperatively. The primary outcome is the proportion of patients undergoing one or more seroma aspirations. Secondary outcome measures consist of the number of invasive interventions, surgical site infection, quality of life measured using the SF-12 Health Survey, cosmesis, pain and number of additional outpatient department visits.
DISCUSSION
CONCLUSIONS
To our knowledge, no randomized controlled trial has been conducted comparing flap fixation with and without closed-suction drainage with seroma aspiration as the primary outcome. This study could result in finding evidence that supports performing mastectomy without closed-suction drainage.
TRIAL REGISTRATION
BACKGROUND
This trial was approved by the medical ethical committee of Zuyderland Medical Center METC-Z on 20 March 2019 (METCZ20190023). The SARA Trial was registered at ClinicalTrials.gov as per July 2019, Identifier: NCT04035590 .
Identifiants
pubmed: 32767988
doi: 10.1186/s12885-020-07242-0
pii: 10.1186/s12885-020-07242-0
pmc: PMC7412663
doi:
Banques de données
ClinicalTrials.gov
['NCT04035590']
Types de publication
Clinical Trial Protocol
Equivalence Trial
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
735Références
Breast Cancer. 2016 May;23(3):486-90
pubmed: 25874687
Breast Cancer. 2006;13(3):260-5
pubmed: 16929119
World J Surg Oncol. 2012 Jan 11;10:8
pubmed: 22236813
Breast. 2005 Apr;14(2):103-7
pubmed: 15767179
Ann Surg. 1992 Feb;215(2):146-9
pubmed: 1546900
Am J Surg. 2010 Sep;200(3):352-6
pubmed: 20409509
Ann Surg Oncol. 2015 Dec;22(13):4233-40
pubmed: 25783681
Breast. 2019 Aug;46:81-86
pubmed: 31103811
Eur J Surg Oncol. 2001 Feb;27(1):26-30
pubmed: 11237488
Br J Surg. 2002 Mar;89(3):286-92
pubmed: 11872051
J R Coll Surg Edinb. 1995 Oct;40(5):292-4
pubmed: 8523301
Ann R Coll Surg Engl. 1997 Nov;79(6):435-7
pubmed: 9422871
Surgeon. 2017 Oct;15(5):267-271
pubmed: 26907221
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
Br J Surg. 2006 Jul;93(7):810-9
pubmed: 16775816
Breast Care (Basel). 2010;5(2):97-101
pubmed: 20847821
Eur J Surg Oncol. 2013 Apr;39(4):334-8
pubmed: 23380200
ANZ J Surg. 2006 Dec;76(12):1088-95
pubmed: 17199696
Ann Surg Oncol. 2014 Mar;21(3):802-7
pubmed: 24217790
World J Surg Oncol. 2016 Mar 08;14:66
pubmed: 26952040
Breast J. 2013 Sep-Oct;19(5):478-84
pubmed: 23865902
Eur J Surg Oncol. 2011 Oct;37(10):829-35
pubmed: 21849243
Clin Breast Cancer. 2017 Dec;17(8):595-600
pubmed: 28673765
J Korean Med Sci. 2009 Feb;24(1):92-6
pubmed: 19270819
Int J Surg. 2014 Nov;12(11):1210-5
pubmed: 25462702
Breast Cancer Res Treat. 2018 Jan;167(2):409-416
pubmed: 29039118
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Int J Surg. 2015 Jan;13:170-174
pubmed: 25486263
Am Surg. 2000 May;66(5):444-50; discussion 450-1
pubmed: 10824744
Br J Surg. 2004 Jan;91(1):54-60
pubmed: 14716794
Cureus. 2017 Jul 10;9(7):e1454
pubmed: 28929038
Clin Breast Cancer. 2017 Jul;17(4):316-321
pubmed: 28202253